Etie S. Moghissi, MD, FACP, FACE, Now Affiliated with the Doctors of Saint John's Medical Group, Endocrinology and Diabetes, Los Angeles, CA

Publications

  1. SHIFTING PARADIGMS IN THE MEDICAL MANAGEMENT OF TYPE 2 DIABETES: REFLECTIONS ON RECENT CARDIOVASCULAR OUTCOME TRIALS
    Ismail-Beigi F, Moghissi E, Kosiborod M, Inzucchi SE.
    J Gen Intern Med. 2017 May 26.

  2. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY – CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN – 2015
    Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, Blonde L, Bray GA, Cohen AJ, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda OP, Garber AJ, Garvey WT, Henry RR, Hirsch IB, Horton ES, Hurley DL, Jellinger PS, Jovanovič L, Lebovitz HE, LeRoith D, Levy P, McGill JB, Mechanick JI, Mestman JH, Moghissi ES, Orzeck EA, Pessah-Pollack R, Rosenblit PD, Vinik AI, Wyne K, Zangeneh F.
    Endocr Pract. 2015 Apr;21 Suppl 1:1-87.

  3. HYPERGLYCEMIA GRAND ROUNDS: DESCRIPTIVE FINDINGS OF OUTCOMES FROM A CONTINUING EDUCATION INTERVENTION TO IMPROVE GLYCEMIC CONTROL AND PREVENT HYPOGLYCEMIA IN THE HOSPITAL SETTING
    Moghissi ES, Inzucchi SE, Mann KV, Byerly B, Ermentrout L, Juchniewicz JJ, Ferareza JH, Kirkwood N.
    Hosp Pract (1995). 2015;43(5):270-6. Epub 2015 Nov 2.

  4. INDIVIDUALIZING INSULIN THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES
    Moghissi E, King AB.
    Am J Med. 2014 Oct;127(10 Suppl):S3-10.

  5. TREATING PATIENTS WITH DIABETES OF LONG DURATION: GLP-1 RECEPTOR AGONISTS AND INSULIN IN COMBINATION
    Moghissi ES.
    J Am Osteopath Assoc. 2014 May;114(5 Suppl 2):S22-9. Review.

  6. MANAGEMENT OF TYPE 2 DIABETES MELLITUS IN OLDER PATIENTS: CURRENT AND EMERGING TREATMENT OPTIONS
    Moghissi ES.
    Diabetes Ther. 2013 Dec;4(2):239-56. Epub 2013 Oct 5.

  7. PATHWAYS TO QUALITY INPATIENT MANAGEMENT OF HYPERGLYCEMIA AND DIABETES: A CALL TO ACTION
    Draznin B, Gilden J, Golden SH, Inzucchi SE; PRIDE investigators, Baldwin D, Bode BW, Boord JB, Braithwaite SS, Cagliero E, Dungan KM, Falciglia M, Figaro MK, Hirsch IB, Klonoff D, Korytkowski MT, Kosiborod M, Lien LF, Magee MF, Masharani U, Maynard G, McDonnell ME, Moghissi ES, Rasouli N, Rubin DJ, Rushakoff RJ, Sadhu AR, Schwartz S, Seley JJ, Umpierrez GE, Vigersky RA, Low CC, Wexler DJ.
    Diabetes Care. 2013 Jul;36(7):1807-14.

  8. HYPOGLYCEMIA: MINIMIZING ITS IMPACT IN TYPE 2 DIABETES
    Moghissi E, Ismail-Beigi F, Devine RC.
    Endocr Pract. 2013 May-Jun;19(3):526-35. Review.

  9. A LOOK INTO THE FUTURE: IMPROVING DIABETES CARE BY 2015
    Brunton S, Gough S, Hicks D, Weng J, Moghissi E, Peyrot M, Schneider D, Maria Schumm-Draeger P, Tobin C, Barnett AH.
    Curr Med Res Opin. 2011 Nov;27 Suppl 3:65-72. Epub 2011 Jul 25.

  10. DIVERSITY IN DIABETES: THE ROLE OF INSULIN ASPART
    Heller S, McCance DR, Moghissi E, Nazeri A, Kordonouri O.
    Diabetes Metab Res Rev. 2012 Jan;28(1):50-61. Review.

  11. INTENSIVE INSULIN THERAPY IN HOSPITALIZED PATIENTS
    Korytkowski M, Moghissi E, Umpierrez G
    Ann Intern Med. 2011 Jun 21;154(12):846-7; author reply 847-8. No abstract available.

  12. INDIVIDUALIZING GLYCEMIC TARGETS IN TYPE 2 DIABETES MELLITUS: IMPLICATIONS OF RECENT CLINICAL TRIALS
    Ismail-Beigi F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S
    Ann Intern Med. 2011 Apr 19;154(8):554-9. Review.

  13. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN
    Handelsman Y, Mechanick JI, Blonde L, Grunberger G, Bloomgarden ZT, Bray GA, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda O, Garber AJ, Hirsch IB, Horton ES, Ismail-Beigi F, Jellinger PS, Jones KL, Jovanovič L, Lebovitz H, Levy P, Moghissi ES, Orzeck EA, Vinik AI, Wyne KL; AACE Task Force for Developing Diabetes Comprehensive Care Plan.
    Endocr Pract. 2011 Mar-Apr;17 Suppl 2:1-53.

  14. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN: EXECUTIVE SUMMARY
    Handelsman Y, Mechanick JI, Blonde L, Grunberger G, Bloomgarden ZT, Bray GA, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda O, Garber AJ, Hirsch IB, Horton ES, Ismail-Beigi F, Jellinger PS, Jones KL, Jovanovič L, Lebovitz H, Levy P, Moghissi ES, Orzeck EA, Vinik AI, Wyne KL; AACE Task Force for Developing a Diabetes Comprehensive Care Plan.
    Endocr Pract. 2011 Mar-Apr;17(2):287-302.

  15. STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS CONSENSUS PANEL ON INSULIN PUMP MANAGEMENT
    Grunberger G, Bailey TS, Cohen AJ, Flood TM, Handelsman Y, Hellman R, Jovanovič L, Moghissi ES, Orzeck EA; AACE Insulin Pump Management Task Force.
    Endocr Pract. 2010 Sep-Oct;16(5):746-62.

  16. REEXAMINING THE EVIDENCE FOR INPATIENT GLUCOSE CONTROL: NEW RECOMMENDATIONS FOR GLYCEMIC TARGETS
    Moghissi ES
    Am J Health Syst Pharm. 2010 Aug;67(16 Suppl 8):S3-8. Review.

  17. IMPORTANT UPDATES ON THE MANAGEMENT OF INPATIENT HYPERGLYCEMIA: PRACTICAL IMPLICATIONS FOR PHARMACISTS. INTRODUCTION
    Moghissi ES
    Am J Health Syst Pharm. 2010 Aug;67(16 Suppl 8):S2. No abstract available.

  18. ADDRESSING HYPERGLYCEMIA FROM HOSPITAL ADMISSION TO DISCHARGE
    Moghissi ES
    Curr Med Res Opin. 2010 Mar;26(3):589-98. Review.

  19. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY EXECUTIVE SUMMARY
    Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R; Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines.
    Endocr Pract. 2016 Jul;22(7):842-84.

  20. COMPARISONS OF DIFFERENT INSULIN INFUSION PROTOCOLS: A REVIEW OF RECENT LITERATURE
    Krikorian A, Ismail-Beigi F, Moghissi ES.
    Curr Opin Clin Nutr Metab Care. 2010 Mar;13(2):198-204. Review.

  21. STATEMENT BY AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CONSENSUS PANEL ON TYPE 2 DIABETES MELLITUS: AN ALGORITHM FOR GLYCEMIC CONTROL
    Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G, Handelsman Y, Horton ES, Lebovitz H, Levy P, Moghissi ES, Schwartz SS.
    Endocr Pract. 2009 Sep-Oct;15(6):540-59. Erratum in: Endocr Pract. 2009 Nov-Dec;15(7):768-70.

  22. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY – CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN – 2015 – EXECUTIVE SUMMARY
    Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, Blonde L, Bray GA, Cohen AJ, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda OP, Garber AJ, Garvey WT, Henry RR, Hirsch IB, Horton ES, Hurley DL, Jellinger PS, Jovanovič L, Lebovitz HE, LeRoith D, Levy P, McGill JB, Mechanick JI, Mestman JH, Moghissi ES, Orzeck EA, Pessah-Pollack R, Rosenblit PD, Vinik AI, Wyne K, Zangeneh F.
    Endocr Pract. 2015 Apr;21(4):413-37. No abstract available.

  23. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN DIABETES ASSOCIATION CONSENSUS STATEMENT ON INPATIENT GLYCEMIC CONTROL
    Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE; American Association of Clinical Endocrinologists; American Diabetes Association.
    Endocr Pract. 2009 May-Jun;15(4):353-69. No abstract available

  24. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN DIABETES ASSOCIATION CONSENSUS STATEMENT ON INPATIENT GLYCEMIC CONTROL
    Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE; American Association of Clinical Endocrinologists; American Diabetes Association.
    Diabetes Care. 2009 Jun;32(6):1119-31. doi: 10.2337/dc09-9029. Epub 2009 May 8. No abstract available.

  25. INSULIN STRATEGIES FOR MANAGING INPATIENT AND OUTPATIENT HYPERGLYCEMIA AND DIABETES
    Moghissi ES.
    Mt Sinai J Med. 2008 Dec 1;75(6):558-66. Review.

  26. DIAGNOSIS AND MANAGEMENT OF PREDIABETES IN THE CONTINUUM OF HYPERGLYCEMIA: WHEN DO THE RISKS OF DIABETES BEGIN? A CONSENSUS STATEMENT FROM THE AMERICAN COLLEGE OF ENDOCRINOLOGY AND THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS
    Garber AJ, Handelsman Y, Einhorn D, Bergman DA, Bloomgarden ZT, Fonseca V, Garvey WT, Gavin JR 3rd, Grunberger G, Horton ES, Jellinger PS, Jones KL, Lebovitz H, Levy P, McGuire DK, Moghissi ES, Nesto RW.
    Endocr Pract. 2008 Oct;14(7):933-46. No abstract available.

  27. GLYCEMIA MANAGEMENT AND CARDIOVASCULAR RISK IN TYPE 2 DIABETES: AN EVOLVING PERSPECTIVE
    Ismail-Beigi F, Moghissi ES.
    Endocr Pract. 2008 Jul-Aug;14(5):639-43. Review.

  28. GLYCEMIA MANAGEMENT AND CARDIOVASCULAR RISK IN TYPE 2 DIABETES: AN EVOLVING PERSPECTIVE
    Ismail-Beigi F, Moghissi ES.
    Endocr Pract. 2008 Jul-Aug;14(5):639-43. Review.

  29. INPATIENT POINT-OF-CARE BEDSIDE GLUCOSE TESTING: PRELIMINARY DATA ON USE OF CONNECTIVITY INFORMATICS TO MEASURE HOSPITAL GLYCEMIC CONTROL
    Cook CB, Moghissi E, Joshi R, Kongable GL, Abad VJ.
    Diabetes Technol Ther. 2007 Dec;9(6):493-500.

  30. INSULIN INFUSION PROTOCOLS FOR CRITICALLY ILL PATIENTS: A HIGHLIGHT OF DIFFERENCES AND SIMILARITIES
    Nazer LH, Chow SL, Moghissi ES.
    Endocr Pract. 2007 Mar-Apr;13(2):137-46.

  31. HOSPITAL MANAGEMENT OF DIABETES
    Moghissi ES, Hirsch IB.
    Endocrinol Metab Clin North Am. 2005 Mar;34(1):99-116. Review.

  32. HOSPITAL MANAGEMENT OF DIABETES: BEYOND THE SLIDING SCALE
    Moghissi E.
    Cleve Clin J Med. 2004 Oct;71(10):801-8. Review.

  33. AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON INPATIENT DIABETES AND METABOLIC CONTROL
    Garber AJ, Moghissi ES, Bransome ED Jr, Clark NG, Clement S, Cobin RH, Furnary AP, Hirsch IB, Levy P, Roberts R, Van den Berghe G, Zamudio V; American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control.
    Endocr Pract. 2004 Mar-Apr;10 Suppl 2:4-9. No abstract available.

  34. AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON INPATIENT DIABETES AND METABOLIC CONTROL
    Garber AJ, Moghissi ES, Bransome ED Jr, Clark NG, Clement S, Cobin RH, Furnary AP, Hirsch IB, Levy P, Roberts R, Van den Berghe G, Zamudio V; American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control.
    Endocr Pract. 2004 Jan-Feb;10(1):77-82. No abstract available.

  35. TYPE 2 DIABETES MELLITUS
    Moghissi E, Mestman J.
    Diabetes Technol Ther. 2000;2 Suppl 1:S61-5. No abstract available.

  36. ORIGIN OF PLASMA ANDROSTANEDIOL GLUCURONIDE IN MEN
    Moghissi E, Ablan F, Horton R.
    J Clin Endocrinol Metab. 1984 Sep;59(3):417-21.

  37. THE ORIGIN OF PLASMA DEOXYCORTICOSTERONE IN THE SYNDROME OF CONGENITAL ADRENAL HYPERPLASIA AND IN ACUTE STATES OF ADRENOCORTICOTROPIN EXCESS
    Antonipillai I, Moghissi E, Frasier SD, Horton R.
    J Clin Endocrinol Metab. 1983 Sep;57(3):580-4. No abstract available.

  38. THE ORIGIN OF PLASMA DEOXYCORTICOSTERONE IN MEN AND IN WOMEN DURING THE MENSTRUAL CYCLE
    Antonipillai I, Moghissi E, Hawks D, Schneider T, Horton R.
    J Clin Endocrinol Metab. 1983 Jan;56(1):93-8. No abstract available.

  39. CONVERSION OF PROGESTERONE FROM THE ADRENAL OR OVARY TO DEOXYCORTICOSTERONE IN PLASMA
    Antonipillai I, Moghissi E, Frasier SD, Horton R.
    Clin Exp Hypertens A. 1982;4(9-10):1519-27.